{
 "drug": "Oxaliplatin Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "10/20/2025",
 "dayN": 309,
 "cat": "Oncology",
 "companies": [
  "Sandoz Inc.",
  "Fresenius Kabi USA, LLC",
  "Jiangsu Hengrui Pharmaceuticals Co., Ltd."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "10/20/2025",
   "update_type": "New",
   "initial_posting_date": "10/20/2025",
   "package_ndc": "0781-3317-80",
   "generic_name": "Oxaliplatin Injection",
   "contact_info": "800-525-8747",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA078817"
    ],
    "brand_name": [
     "OXALIPLATIN"
    ],
    "generic_name": [
     "OXALIPLATIN"
    ],
    "manufacturer_name": [
     "Sandoz Inc"
    ],
    "product_ndc": [
     "0781-3317",
     "0781-3315"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "OXALIPLATIN"
    ],
    "rxcui": [
     "1736776",
     "1736781"
    ],
    "spl_id": [
     "f3766495-fce3-461c-8c95-e890f5e3383f"
    ],
    "spl_set_id": [
     "ab162009-6f84-4d56-ab56-5e84409ec814"
    ],
    "package_ndc": [
     "0781-3315-70",
     "0781-3317-80"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "04ZR38536J"
    ]
   },
   "update_date": "10/20/2025",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3317-80)",
   "company_name": "Sandoz Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "02/25/2026",
   "update_type": "New",
   "initial_posting_date": "02/25/2026",
   "package_ndc": "63323-750-20",
   "generic_name": "Oxaliplatin Injection",
   "contact_info": "847-550-2300",
   "related_info": "A business decision was made to discontinue manufacture of the drug.",
   "update_date": "02/25/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-20)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "10/20/2025",
   "update_type": "New",
   "initial_posting_date": "10/20/2025",
   "package_ndc": "0781-3315-70",
   "generic_name": "Oxaliplatin Injection",
   "contact_info": "800-525-8747",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA078817"
    ],
    "brand_name": [
     "OXALIPLATIN"
    ],
    "generic_name": [
     "OXALIPLATIN"
    ],
    "manufacturer_name": [
     "Sandoz Inc"
    ],
    "product_ndc": [
     "0781-3315",
     "0781-3317"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "OXALIPLATIN"
    ],
    "rxcui": [
     "1736776",
     "1736781"
    ],
    "spl_id": [
     "f3766495-fce3-461c-8c95-e890f5e3383f"
    ],
    "spl_set_id": [
     "ab162009-6f84-4d56-ab56-5e84409ec814"
    ],
    "package_ndc": [
     "0781-3315-70",
     "0781-3317-80"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "04ZR38536J"
    ]
   },
   "update_date": "10/20/2025",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3315-70)",
   "company_name": "Sandoz Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "02/25/2026",
   "update_type": "New",
   "initial_posting_date": "02/25/2026",
   "package_ndc": "63323-750-10",
   "generic_name": "Oxaliplatin Injection",
   "contact_info": "847-550-2300",
   "related_info": "A business decision was made to discontinue manufacture of the drug.",
   "update_date": "02/25/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-10)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "06/29/2026",
   "update_type": "New",
   "initial_posting_date": "06/29/2026",
   "package_ndc": "25021-233-20",
   "generic_name": "Oxaliplatin Injection",
   "contact_info": "Sagent Pharmaceuticals: 866-625-1618",
   "related_info": "Marketed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA203869"
    ],
    "brand_name": [
     "OXALIPLATIN"
    ],
    "generic_name": [
     "OXALIPLATIN"
    ],
    "manufacturer_name": [
     "Sagent Pharmaceuticals"
    ],
    "product_ndc": [
     "25021-233"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "OXALIPLATIN"
    ],
    "rxcui": [
     "1736776",
     "1736781"
    ],
    "spl_id": [
     "c159050a-e588-4091-b9ee-ea502e1b9529"
    ],
    "spl_set_id": [
     "29a5d098-bfa7-4a65-bb4f-5daa1fef1c2f"
    ],
    "package_ndc": [
     "25021-233-10",
     "25021-233-20"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "04ZR38536J"
    ]
   },
   "update_date": "06/29/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-20)",
   "company_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "06/29/2026",
   "update_type": "New",
   "initial_posting_date": "06/29/2026",
   "package_ndc": "25021-233-10",
   "generic_name": "Oxaliplatin Injection",
   "contact_info": "Sagent Pharmaceuticals: 866-625-1618",
   "related_info": "Marketed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA203869"
    ],
    "brand_name": [
     "OXALIPLATIN"
    ],
    "generic_name": [
     "OXALIPLATIN"
    ],
    "manufacturer_name": [
     "Sagent Pharmaceuticals"
    ],
    "product_ndc": [
     "25021-233"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "OXALIPLATIN"
    ],
    "rxcui": [
     "1736776",
     "1736781"
    ],
    "spl_id": [
     "c159050a-e588-4091-b9ee-ea502e1b9529"
    ],
    "spl_set_id": [
     "29a5d098-bfa7-4a65-bb4f-5daa1fef1c2f"
    ],
    "package_ndc": [
     "25021-233-10",
     "25021-233-20"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "04ZR38536J"
    ]
   },
   "update_date": "06/29/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-10)",
   "company_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
   "status": "To Be Discontinued"
  }
 ]
}